Modern diagnosis and therapy of benign thyroid diseases

被引:0
作者
Fischli, Stefan [1 ,2 ]
Strobel, Klaus [1 ,3 ]
Lago, Maria del Sol Perez [1 ,3 ]
Arnold, Walter [1 ,4 ]
Wicke, Corinna [1 ]
机构
[1] Luzerner Kantonsspital, Schilddrusenzentrum, Spitalstr, CH-6000 Luzern 16, Switzerland
[2] Luzerner Kantonsspital, Endokrinol & Diabetol, Luzern, Switzerland
[3] Luzerner Kantonsspital, Radiol & Nukl Med, Luzern, Switzerland
[4] Luzerner Kantonsspital, Pathol, Luzern, Switzerland
关键词
RADIOIODINE THERAPY; RADIOFREQUENCY ABLATION; GRAVES-DISEASE; NODULES; MANAGEMENT; SUCCESS;
D O I
10.1024/0040-5930/a001212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Benign thyroid diseases continue to be widespread endocrine disorders. Early recognition of their symptoms and exact diagnosis are the prerequisite of targeted therapy and minimal impairment of the patient's well-being. Drug treatment, radioiodine therapy, thermal ablation procedures and surgery have been shown to be successful treatment options. As guidelines for diagnosis and treatment of patients continue to evolve, an interdisciplinary approach ensures optimal diagnosis and management on every step in the care for these patients. We present three clinical scenarios for benign thyroid disease: the symptomatic goitre, the painful thyroid and the thyroid with hyperthyroidism.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 50 条
  • [1] Commentary on the latest DGN procedure guidelines for radioiodine therapy for benign thyroid diseases
    Dietlein, Markus
    Drzezga, Alexander
    Schmidt, Matthias
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2024, 63 (01): : 4 - 7
  • [2] Nuclear medicine in the diagnosis of benign thyroid diseases
    Czepczynski, Rafal
    NUCLEAR MEDICINE REVIEW, 2012, 15 (02) : 113 - 119
  • [3] Guideline for radioiodine therapy for benign thyroid diseases (version 3)
    Dietlein, M
    Dressler, J
    Grünwald, F
    Leisner, B
    Moser, E
    Reiners, C
    Schicha, H
    Schneider, P
    Schober, O
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2004, 43 (06): : 217 - 220
  • [4] Role of Nuclear Medicine in the Diagnosis of Benign Thyroid Diseases
    Garberoglio, Sara
    Testori, Ornella
    IMAGING IN ENDOCRINE DISORDERS, 2016, 45 : 24 - 36
  • [5] Radioiodine therapy for benign thyroid diseases (version 5) German Guideline
    Dietleinl, Markus
    Granwald, Frank
    Schmidt, Matthias
    Schneider, Peter
    Verburg, Frederik A.
    Lusters, Markus
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (06): : 213 - 220
  • [6] Predictive factors for the outcome of radioiodine therapy in patients with benign thyroid diseases
    Wedel, Florian
    Exarchopoulos, Thomas
    Brenner, Winfried
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2024, 63 (02): : 69 - 75
  • [7] Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases
    Christian Happel
    Wolfgang Tilman Kranert
    Hanns Ackermann
    Ina Binse
    Benjamin Bockisch
    Daniel Gröner
    Ken Herrmann
    Frank Grünwald
    Endocrine, 2019, 63 : 537 - 544
  • [8] Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases
    Happel, Christian
    Kranert, Wolfgang Tilman
    Ackermann, Hanns
    Binse, Ina
    Bockisch, Benjamin
    Groener, Daniel
    Herrmann, Ken
    Gruenwald, Frank
    ENDOCRINE, 2019, 63 (03) : 537 - 544
  • [9] Guideline for radioiodine therapy for benign thyroid diseases (version 4)
    Dietlein, M.
    Dressler, J.
    Gruenwald, F.
    Leisner, B.
    Moser, E.
    Reiners, Chr.
    Schicha, H.
    Schneider, P.
    Schober, O.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2007, 46 (05): : 220 - 223
  • [10] PET in Diagnosis of Thyroid Diseases
    Gonzaga Diaz-Gonzalez, Luis
    Garcia-Talavera, Paloma
    Gomez-Caminero, Felipe
    Riola-Parada, Cristina
    Gabriel Villanueva-Curto, Juan
    Tamayo-Alonso, Pilar
    REVISTA ORL, 2020, 11 (03) : 297 - 304